Michael Ramirez, Ph.D.

@Datamonitor_MR

Oncology Analyst @ Datamonitor_HC. Views expressed are my own.

Vrijeme pridruživanja: studeni 2017.

Tweetovi

Blokirali ste korisnika/cu @Datamonitor_MR

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Datamonitor_MR

  1. proslijedio/la je Tweet
    4. velj
    Poništi
  2. 30. sij

    First episode of the year for the Informa Pharma Intelligence Podcast, covering . Listen in as and share their key takeaways from the meeting:

    Poništi
  3. proslijedio/la je Tweet
    16. sij

    What a week it’s been - and it’s only Thursday! Here’s our (free) Day 3 roundup. One more Notebook to come & many stories to follow over the coming weeks from insightful interviews & did on the ground in San Francisco.

    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    15. sij
    Poništi
  5. For all those heading out to this year, check out the Informa Pharma Intelligence Podcast (free) where we preview some abstracts that caught our eye!

    Poništi
  6. New Informa Pharma Intelligence Podcast episode: Pamela Spicer talks aducanumab moving from futility to FDA filing for Alzheimer's disease Amanda Micklus does a cell/gene therapy news round-up

    Poništi
  7. With wrapping up earlier this week, we sat down and discussed some of the presentations that we found interesting on the Informa Pharma Intelligence Podcast. Listen to our analysts' takeaways here:

    Poništi
  8. Just wrapped another episode of the Informa Pharma Intelligence Podcast, this time on NASH and the TMB biomarker: Round out your workweek with a listen!

    Poništi
  9. Very interesting discussion on and proposals under the administration on the Informa Pharma Intelligence Podcast We discuss the Senate Finance Committee proposal, the rebate rule, and International Pricing Index

    Poništi
  10. With now in the rear view mirror, we discuss some last thoughts on this year's conference on the completely free Informa Pharma Intelligence Podcast. Check it out!

    Poništi
  11. proslijedio/la je Tweet
    3. lip 2019.
    Poništi
  12. proslijedio/la je Tweet
    30. svi 2019.

    Publisher’s ASCO Spotlight: Compare Your Insights To Oncologists

    Poništi
  13. Check out our pre- podcast, available for free! David Dahan , Zachary McLellan and I talk about presentations we're looking forward to

    Poništi
  14. Years after being founded by renowned scientist Steven McKnight from UT Southwestern, will now acquire Peloton Therapeutics for $1.05bn. Congrats, and looking forward to the Phase III for PT2977!

    Poništi
  15. We will also be releasing a pre- podcast Friday of next week!

    Poništi
  16. Thanks to Dominique Fontanilla , Laurie Withington , Stephanie Yip and Pammy Spicer for joining the podcast!

    Poništi
  17. New episode of the Informa Pharma Intelligence Podcast now live! Speakers discussed several topics related to the conference, including SMA, migraine, and NMOSD:

    Poništi
  18. proslijedio/la je Tweet
    1. svi 2019.

    Welcome to our twitter chat! Our analysts are ready and waiting to answer your questions! Looking forward to seeing what you all ask!

    Poništi
  19. New episode of the completely free Informa Pharma Intelligence Podcast now live! - Failure of aducanumab - Preview of Meddevicetracker report on device regulatory timing - Recent results for Ocaliva in non-alcoholic steatohepatitis

    Poništi
  20. Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·